BACKGROUND: Although chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by Th2 inflammation, the mechanism underlying the onset and amplification of this inflammation has not been fully elucidated. Dendritic cells (DCs) are major antigen-presenting cells, central inducers of adaptive immunity and critical regulators of many inflammatory diseases. However, the presence of DCs in CRS, especially in nasal polyps (NPs), has not been extensively studied. OBJECTIVE: The objective of this study was to characterize DC subsets in CRS. METHODS: We used real-time PCR to assess the expression of mRNA for markers of myeloid DCs (mDCs; CD1c), plasmacytoid DCs (pDCs; CD303) and Langerhans cells (LCs; CD1a, CD207) in uncinate tissue (UT) from controls and patients with CRS as well as in NP. We assayed the presence of DCs by immunohistochemistry and flow cytometry. RESULTS: Compared to UT from control subjects (n = 15) and patients with CRS without NP (CRSsNP) (n = 16) and CRSwNP (n = 17), mRNAs for CD1a and CD1c were significantly elevated in NPs (n = 29). In contrast, CD207 mRNA was not elevated in NPs. Immunohistochemistry showed that CD1c(+) cells but not CD303(+) cells were significantly elevated in NPs compared to control subjects or patients with CRSsNP. Flow cytometric analysis showed that CD1a(+) cells in NPs might be a subset of mDC1s and that CD45(+) CD19(-) CD1c(+) CD11c(+) CD141(-) CD303(-) HLA-DR(+) mDC1s and CD45(+) CD19(-) CD11c(+) CD1c(-) CD141(high) HLA-DR(+) mDC2s were significantly elevated in NPs compared to UT from controls and CRSsNP, but CD45(+) CD11c(-) CD303(+) HLA-DR(+) pDCs were only elevated in NPs compared to control UT. CONCLUSION AND CLINICAL RELEVANCE: Myeloid DCs are elevated in CRSwNP, especially in NPs. Myeloid DCs thus may indirectly contribute to the inflammation observed in CRSwNP.
BACKGROUND: Although chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by Th2inflammation, the mechanism underlying the onset and amplification of this inflammation has not been fully elucidated. Dendritic cells (DCs) are major antigen-presenting cells, central inducers of adaptive immunity and critical regulators of many inflammatory diseases. However, the presence of DCs in CRS, especially in nasal polyps (NPs), has not been extensively studied. OBJECTIVE: The objective of this study was to characterize DC subsets in CRS. METHODS: We used real-time PCR to assess the expression of mRNA for markers of myeloid DCs (mDCs; CD1c), plasmacytoid DCs (pDCs; CD303) and Langerhans cells (LCs; CD1a, CD207) in uncinate tissue (UT) from controls and patients with CRS as well as in NP. We assayed the presence of DCs by immunohistochemistry and flow cytometry. RESULTS: Compared to UT from control subjects (n = 15) and patients with CRS without NP (CRSsNP) (n = 16) and CRSwNP (n = 17), mRNAs for CD1a and CD1c were significantly elevated in NPs (n = 29). In contrast, CD207 mRNA was not elevated in NPs. Immunohistochemistry showed that CD1c(+) cells but not CD303(+) cells were significantly elevated in NPs compared to control subjects or patients with CRSsNP. Flow cytometric analysis showed that CD1a(+) cells in NPs might be a subset of mDC1s and that CD45(+) CD19(-) CD1c(+) CD11c(+) CD141(-) CD303(-) HLA-DR(+) mDC1s and CD45(+) CD19(-) CD11c(+) CD1c(-) CD141(high) HLA-DR(+) mDC2s were significantly elevated in NPs compared to UT from controls and CRSsNP, but CD45(+) CD11c(-) CD303(+) HLA-DR(+) pDCs were only elevated in NPs compared to control UT. CONCLUSION AND CLINICAL RELEVANCE: Myeloid DCs are elevated in CRSwNP, especially in NPs. Myeloid DCs thus may indirectly contribute to the inflammation observed in CRSwNP.
Authors: Li-Li Shi; Jia Song; Peng Xiong; Ping-Ping Cao; Bo Liao; Jin Ma; Ya-Na Zhang; Ming Zeng; Yang Liu; Heng Wang; Yong-Hua Cui; Shau-Ku Huang; Zheng Liu Journal: Am J Respir Crit Care Med Date: 2014-09-15 Impact factor: 21.405
Authors: Brendan P O'Connell; Rodney J Schlosser; Jennifer L Wentzel; Whitney Nagel; Jennifer K Mulligan Journal: Otolaryngol Head Neck Surg Date: 2013-12-23 Impact factor: 3.497
Authors: Deepti R Nagarkar; Julie A Poposki; Bruce K Tan; Michael R Comeau; Anju T Peters; Kathryn E Hulse; Lydia A Suh; James Norton; Kathleen E Harris; Leslie C Grammer; Rakesh K Chandra; David B Conley; Robert C Kern; Robert P Schleimer; Atsushi Kato Journal: J Allergy Clin Immunol Date: 2013-05-17 Impact factor: 10.793
Authors: Sudarshan Seshadri; Mariel Rosati; David C Lin; Roderick G Carter; James E Norton; Andrew Wonho Choi; Lydia Suh; Atsushi Kato; Rakesh K Chandra; Kathleen E Harris; Hong Wei Chu; Anju T Peters; Bruce K Tan; David B Conley; Leslie C Grammer; Robert C Kern; Robert P Schleimer Journal: J Allergy Clin Immunol Date: 2013-07-26 Impact factor: 10.793
Authors: Julie A Poposki; Aiko I Klingler; Whitney W Stevens; Anju T Peters; Kathryn E Hulse; Leslie C Grammer; Robert P Schleimer; Kevin C Welch; Stephanie S Smith; Douglas M Sidle; David B Conley; Bruce K Tan; Robert C Kern; Atsushi Kato Journal: J Allergy Clin Immunol Date: 2016-10-12 Impact factor: 10.793
Authors: Y Imoto; A Kato; T Takabayashi; M Sakashita; J E Norton; L A Suh; R G Carter; A R Weibman; K E Hulse; W Stevens; K E Harris; A T Peters; L C Grammer; B K Tan; K Welch; D B Conley; R C Kern; S Fujieda; R P Schleimer Journal: Clin Exp Allergy Date: 2018-03-24 Impact factor: 5.018
Authors: Jennifer K Mulligan; Brendan P O'Connell; Whitney Pasquini; Ryan M Mulligan; Sarah Smith; Zachary M Soler; Carl Atkinson; Rodney J Schlosser Journal: Int Forum Allergy Rhinol Date: 2017-06-02 Impact factor: 3.858
Authors: Julie A Poposki; Anjeni Keswani; Julie K Kim; Aiko I Klingler; Lydia A Suh; James Norton; Roderick G Carter; Anju T Peters; Kathryn E Hulse; Leslie C Grammer; Bruce K Tan; David B Conley; Juan C Jaen; Thomas J Schall; Robert C Kern; Atsushi Kato Journal: J Allergy Clin Immunol Date: 2015-11-10 Impact factor: 10.793
Authors: Aiko I Klingler; Whitney W Stevens; Bruce K Tan; Anju T Peters; Julie A Poposki; Leslie C Grammer; Kevin C Welch; Stephanie S Smith; David B Conley; Robert C Kern; Robert P Schleimer; Atsushi Kato Journal: J Allergy Clin Immunol Date: 2020-12-14 Impact factor: 10.793
Authors: Atsushi Kato; Anju T Peters; Whitney W Stevens; Robert P Schleimer; Bruce K Tan; Robert C Kern Journal: Allergy Date: 2021-09-15 Impact factor: 14.710